# The Role of Microbiome Reprogramming on Liver Fat Accumulation

> **NCT03914495** · NA · TERMINATED · sponsor: **AdventHealth Translational Research Institute** · enrollment: 57 (actual)

## Conditions studied

- NAFLD

## Interventions

- **DIETARY_SUPPLEMENT:** Inulin
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT03914495
- **Lead sponsor:** AdventHealth Translational Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-05-21
- **Primary completion:** 2021-06-02
- **Final completion:** 2021-06-09
- **Target enrollment:** 57 (ACTUAL)
- **Why stopped:** PI carefully considered multiple factors and decided to close study to any further enrollment.
- **Last updated:** 2023-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03914495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03914495, "The Role of Microbiome Reprogramming on Liver Fat Accumulation". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03914495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*